Citation Impact
Citing Papers
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
On Robots and Insurance
2016
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
An Update on in Vivo Imaging of Extracellular Vesicles as Drug Delivery Vehicles
2018
Combination of Adjuvant Hormonal and Radiation Therapy Significantly Prolongs Survival of Patients With pT2–4 pN+ Prostate Cancer: Results of a Matched Analysis
2011
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy
2007
Systematic Review and Cumulative Analysis of Perioperative Outcomes and Complications After Robot-assisted Radical Cystectomy
2015
Mapping of Pelvic Lymph Node Metastases in Prostate Cancer
2012
Liposomal nanomedicines in the treatment of prostate cancer
2013
Therapeutic Efficacy Evaluation of111In-Labeled PEGylated Liposomal Vinorelbine in Murine Colon Carcinoma with Multimodalities of Molecular Imaging
2009
Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherapy
2015
MicroRNA-150 Is a Potential Biomarker of HIV/AIDS Disease Progression and Therapy
2014
Oxidative stress induced in rat liver by anticancer drugs doxorubicin, paclitaxel and docetaxel
2013
Impact of skeletal complications on patients’ quality of life, mobility, and functional independence
2008
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
2016
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
2007
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
A serum-circulating long noncoding RNA signature can discriminate between patients with clear cell renal cell carcinoma and healthy controls
2016
Survival Benefit of Radical Prostatectomy in Lymph Node–Positive Patients with Prostate Cancer
2010
EAU Guidelines on Prostate Cancer
2007 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review)
2012
Percentage of positive biopsies predicts lymph node involvement in men with low‐risk prostate cancer undergoing radical prostatectomy and extended pelvic lymphadenectomy
2010
Androgen-Deprivation Therapy for Nonmetastatic Prostate Cancer Is Associated With an Increased Risk of Peripheral Arterial Disease and Venous Thromboembolism
2012
11C-Choline Positron Emission Tomography/Computerized Tomography for Preoperative Lymph-Node Staging in Intermediate-Risk and High-Risk Prostate Cancer: Comparison with Clinical Staging Nomograms
2008
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Prostate cancer in the elderly
2011
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Liposomes as nanomedical devices
2015 Standout
Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates
2011
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
2014 Standout
Two Positive Nodes Represent a Significant Cut-off Value for Cancer Specific Survival in Patients with Node Positive Prostate Cancer. A New Proposal Based on a Two-Institution Experience on 703 Consecutive N+ Patients Treated with Radical Prostatectomy, Extended Pelvic Lymph Node Dissection and Adjuvant Therapy
2008
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
2006 Standout
Adiponectin as a growth inhibitor in prostate cancer cells
2005
Treatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000–2008)
2013
Clinical significance of a prostate-specific antigen flare phenomenon in patients with hormone-refractory prostate cancer receiving docetaxel
2006
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
2017 Standout
New Therapeutic Approach to Suppress Castration-Resistant Prostate Cancer Using ASC-J9 via Targeting Androgen Receptor in Selective Prostate Cells
2012
Systematic Review and Cumulative Analysis of Oncologic and Functional Outcomes After Robot-assisted Radical Cystectomy
2015
Clinical Pharmacology of Liposomal Anthracyclines: Focus on Pegylated Liposomal Doxorubicin
2008
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Enhanced Recovery After Surgery
2017 Standout
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
A New Concept for Early Recovery after Surgery for Patients Undergoing Radical Cystectomy for Bladder Cancer: Results of a Prospective Randomized Study
2013
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
Systematic review of outcomes used to evaluate enhanced recovery after surgery
2014
Esterase- and pH-responsive poly(β-amino ester)-capped mesoporous silica nanoparticles for drug delivery
2015 StandoutNobel
Artificial Intelligence Policy: A Roadmap
2017 Standout
Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology
2007 Standout
Absolute and Relative Risk of Cardiovascular Disease in Men With Prostate Cancer: Results From the Population-Based PCBaSe Sweden
2010
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Cancer de la prostate
2007
Works of Carsten‐Henning Ohlmann being referenced
Prospective randomized Phase II trial of pegylated doxorubicin in the management of symptomatic hormone‐refractory prostate carcinoma
2004
MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels
2011
Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma
2011
Anatomical Extent of Pelvic Lymphadenectomy in Patients Undergoing Radical Prostatectomy
2007
da Vinci and Open Radical Prostatectomy: Comparison of Clinical Outcomes and Analysis of Insurance Costs
2015
Ibandronate in metastatic bone pain
2004
Letaler Ausgang einer Chemotherapie mit Docetaxel
2007
Androgendeprivation in der Therapie des Prostatakarzinoms
2008
SECOND-LINE CHEMOTHERAPY WITH DOCETAXEL FOR PROSTATESPECIFIC ANTIGEN (PSA) RELAPSE IN MEN WITH HORMONEREFRACTORY PROSTATE CANCER (HRPC) PREVIOUSLY TREATED WITH DOCETAXEL-BASED CHEMOTHERAPY
2006
Second-line chemotherapy with docetaxel for prostate-specific antigen (PSA) relapse in men with hormone-refractory prostate cancer (HRPC) previously treated with docetaxel-based chemotherapy
2005
825 11C-COLINE-POSITRON EMISSION TOMOGRAPHY/COMPUTERIZED TOMOGRAPHY (C-PET/CT) FOR TUMOR LOCALIZATION OF LOCALLY RECURRENT PROSTATE CANCER AFTER RADIATION THERAPY
2007
Exosomes of invasive urothelial carcinoma cells are characterized by a specific miRNA expression signature
2017
Fast‐track rehabilitation after robot‐assisted laparoscopic cystectomy accelerates postoperative recovery
2012
897 High-dose ibandronate is effective and well tolerated in the treatment of pain and hypercalcaemia due to metastatic urologic cancer
2003